The Brighterside of News on MSN
New study finds 40Hz sensory stimulation may benefit some Alzheimer’s patients for years
A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...
Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
Ottawa Citizen on MSN
Approval of new Alzheimer's drug in Canada called historic
Lecanemab, as the drug is known, was approved by Health Canada this week. It is the first treatment available in Canada to ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...
The Canadian Press on MSN
Health Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease
TORONTO – Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease. Lecanemab is the first ...
The NDA submission is supported by data from two pivotal Phase 3 clinical trials, which evaluated MK-6240’s performance in detecting tau pathology in early Alzheimer’s disease. These studies met their ...
A recent study suggests that two existing drugs, empagliflozin and an experimental insulin nasal spray, may help enhance ...
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...
Everyday Health on MSN
New Blood Test to Rule Out Alzheimer’s Gets FDA Clearance
The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback